Skip to content
★ Sign in to follow
BJ

Beatrice J. Cazala

Executive
Bristol Myers Squibb Co
Total declarations
73
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (5 ops.)
€13.7M

Latest filing published 04 Jun 2013 for Bristol Myers Squibb Co, €3.3M.

Insider track record

Disclosed buys
0
Disclosed sells
5
Signal history

No signal scores available.

Beatrice J. Cazala: trading record in brief

Beatrice J. Cazala appears in our data through filings on Bristol Myers Squibb Co shares, published by SEC (Form 4). Over a trading history stretching from 7 March 2009 to 31 May 2013, the count stands at 73 filings.

The open-market record consists of 5 sales worth €13.7M, with no purchase. Other entries cover 29 share grants and 33 option exercises. 2013 to date brings no purchases and 4 sales.

The record was last updated on 4 June 2013 with an open-market sale (€3.3M) in Bristol Myers Squibb Co. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Beatrice J. Cazala

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations72 total

25 of 72 declarations